These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9951776)

  • 1. Parathyroid hormone stimulates cancellous bone formation at skeletal sites regardless of marrow composition in ovariectomized rats.
    Li M; Liang H; Shen Y; Wronski TJ
    Bone; 1999 Feb; 24(2):95-100. PubMed ID: 9951776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of skeletal response to estrogen depletion at red and yellow marrow sites in rats.
    Li M; Shen Y; Qi H; Wronski TJ
    Anat Rec; 1996 Jul; 245(3):472-80. PubMed ID: 8800405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats.
    Qi H; Li M; Wronski TJ
    J Bone Miner Res; 1995 Jun; 10(6):948-55. PubMed ID: 7572319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of femoral neck to estrogen depletion and parathyroid hormone in aged rats.
    Li M; Wronski TJ
    Bone; 1995 May; 16(5):551-7. PubMed ID: 7544601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats.
    Wronski TJ; Yen CF; Qi H; Dann LM
    Endocrinology; 1993 Feb; 132(2):823-31. PubMed ID: 8425497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
    Baumann BD; Wronski TJ
    Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats.
    Iwaniec UT; Moore K; Rivera MF; Myers SE; Vanegas SM; Wronski TJ
    Osteoporos Int; 2007 Mar; 18(3):351-62. PubMed ID: 17120182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased bone anabolic effect of basic fibroblast growth factor at fatty marrow sites in ovariectomized rats.
    Pun S; Dearden RL; Ratkus AM; Liang H; Wronski TJ
    Bone; 2001 Feb; 28(2):220-6. PubMed ID: 11182382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats.
    Turner RT; Evans GL; Cavolina JM; Halloran B; Morey-Holton E
    Endocrinology; 1998 Oct; 139(10):4086-91. PubMed ID: 9751486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of age, estrogen depletion, and parathyroid hormone treatment on vertebral cancellous wall width in female rats.
    Wronski TJ; Pun S; Liang H
    Bone; 1999 Oct; 25(4):465-8. PubMed ID: 10511114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.
    Kimmel DB; Bozzato RP; Kronis KA; Coble T; Sindrey D; Kwong P; Recker RR
    Endocrinology; 1993 Apr; 132(4):1577-84. PubMed ID: 8462456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Jerome CP; Burr DB; Van Bibber T; Hock JM; Brommage R
    Bone; 2001 Feb; 28(2):150-9. PubMed ID: 11182372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
    Zhou H; Shen V; Dempster DW; Lindsay R
    J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats.
    Watson P; Lazowski D; Han V; Fraher L; Steer B; Hodsman A
    Bone; 1995 Mar; 16(3):357-65. PubMed ID: 7786639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of separate and combined therapy with growth hormone and parathyroid hormone on lumbar vertebral bone in aged ovariectomized osteopenic rats.
    Wang L; Orhii PB; Banu J; Kalu DN
    Bone; 2001 Feb; 28(2):202-7. PubMed ID: 11182379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greater efficacy of alfacalcidol in the red than in the yellow marrow skeletal sites in adult female rats.
    Tian XY; Liu XQ; Chen HY; Setterberg RB; Li M; Jee WS
    J Musculoskelet Neuronal Interact; 2008; 8(3):257-66. PubMed ID: 18799859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone anabolic effects of separate and combined therapy with growth hormone and parathyroid hormone on femoral neck in aged ovariectomized osteopenic rats.
    Wang L; Orhii PB; Banu J; Kalu DN
    Mech Ageing Dev; 2001 Jan; 122(1):89-104. PubMed ID: 11163626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.
    Li M; Mosekilde L; Søgaard CH; Thomsen JS; Wronski TJ
    Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.